Dual Action for Bausch + Lomb - Poll - MDSpire

Dual Action for Bausch + Lomb

Bausch + Lomb advances dry eye therapy to Phase 3 and reports positive Phase 1b results for investigational ocular pain treatment

September 9, 2026
3 min

The Ophthalmologist

Share

Original Source(s)

The Ophthalmologist

Dual Action for Bausch + Lomb

September 9, 2026

Related Content

Digital Health

Insights into the quality and guideline consistency of dry eye disease treatment videos on Chinese short-video platforms

by Ruoyi Yao, Jiahao Ye, Zhounan Zhu, Chen Li
June 3, 2026

Bmc Ophthalmology

Mask-associated dry eye disease following short-term facemask wear with or without nasal bridge taping among health workers at a Nigerian tertiary care facility: a cross-over randomized clinical trial

by Kosisochukwu Perpetual Amaefuna, Regina Enubi Morgan, Charles Obu Bekibele
June 5, 2026

Bmc Ophthalmology

Conjunctival goblet and epithelial cell changes in antidepressant-associated dry eye disease: a case–control study

by Rekha Chotaliya, Neeta Mishra, Neelam Prasad, Archana Buch, Parisha Kelkar, Veshal Madan
June 24, 2026